Health Care Equipment

Beyond Air

BTIG Analyst Maintains Hold Rating on Beyond Air

Beyond Air released FY2026 Semi-Annual Earnings on November 10 After-Market EST, with actual revenue of USD 3.578 M and EPS of USD -2.7473

Beyond Air released FY2026 Q2 earnings on November 10, 2025, After-Market (EST): Actual Revenue USD 1.818 M (Forecast USD 2.536 M), Actual EPS USD -1.2491 (Forecast USD -0.79)

Beyond Air Inc. Publishes SEC 10-Q Report Showing Improved Performance and Product Progress

Beyond Air to Release FY2026 Q2 Earnings on November 10 After-Market EST, Forecast Revenue USD 2.536 M, EPS USD -0.79

Beyond Air released FY2026 Q1 earnings on August 12 After-Market EST, actual revenue USD 1.76 M (forecast USD 1.748 M), actual EPS USD -1.5336 (forecast USD -1.32)

Beyond Air to Release FY2026 Q1 Earnings on August 12 After-Market (EST), Forecast Revenue USD 1.748M, EPS USD -1.32

Beyond Air Inc. Executes 1 for 20 Reverse Stock Split

Beyond Air Shareholders Approve Reverse Stock Split Proposal

Beyond Air Inc. Reports Narrowed Net Loss

Beyond Air released FY2025 Q4 earnings on June 17 After-Market EST, actual revenue USD 1.152 M (forecast USD 1.388 M), actual EPS USD -1.7857 (forecast USD -2.44)

Beyond Air released FY2025 earnings on June 17 After-Market EST: Actual Revenue USD 3.705 M (Forecast USD 3.922 M), Actual EPS USD -13.7726 (Forecast USD -14.84)

Beyond Air Reports Q4 Earnings Beat Expectations

Beyond Air, Inc. Reports 220% Revenue Growth and Submits New Application

Beyond Air's Q4 Earnings Release Before the Fall in Stock Price

Beyond Air Inc expects 195.4% revenue growth in Q1 2025

Beyond Air to Release FY2025 Q4 Earnings on June 17 After-Market EST, Forecast Revenue USD 1.388 M, EPS USD -0.122

Beyond Air to Release Q4 and Full Year 2025 Earnings

Beyond Air Inc. Obtains Patent for NTM Lung Infection Treatment

Beyond Air, Inc. Announces Study Results on High-Dose Intermittent Inhaled Nitric Oxide for Non-Tuberculous Mycobacterial Pulmonary Disease

SEVEN HILLS RLTY TR COM USD0.001 (S/R 04/12/2025)

SMX Security Matters

Polyrizon

Picard Medical

Synchronoss Tech

PharmaCyte Biotech

Q/C Tech

Rich Sparkle

Tradr 2X Long ASTS Daily ETF

Able View Global

Beyond Air, Inc. (XAIR.US) Q2 Fiscal Year 2026 Earnings Conference Call

Beyond Air, Inc. (XAIR.US) Fiscal Year 2025 Fourth Quarter Earnings Conference Call

Beyond Air, Inc. (XAIR.US) Q3 Fiscal Year 2025 Earnings Conference Call

Beyond Air, Inc. (XAIR.US) Q2 Fiscal Year 2025 Earnings Conference Call

Delcath

Electromed

Abbott Laboratories

Intuitive Surgical

Boston Scientific

Stryker

IDEXX Labs

Edwards Lifesciences

Resmed

Steris

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap